Castle Biosciences, Inc.
Castle Biosciences, Inc.（CSTL）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
cstl · 股价预测 · 11 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$52.00
Consensus
$44.80
+122.7% upside
Low
$35.00
Median: $47 · Last Close: $20.12
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$44.80
122.7% upside
High Target
$52
158.4%
Low Target
$35
74.0%
Current Price
$20.12
as of today
Based on analyst price targets, the CSTL stock price prediction for the next 12 months ranges from $35 to $52. The consensus CSTL price forecast of $44.80 implies 122.7% upside from the current price of $20.12.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $20.56 | ↑ 2.19% |
1-day model range: $20.3–$20.82. Peak: $20.82 (+2.19%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $23 | +13.9% |
| 2028 | $25 | +22.6% |
| 2029 | $26 | +27.8% |
| 2030 | $26 | +30.7% |
| 2031 | — | +32.4% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CSTL · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-13 | BTIG | Maintains | Buy→Buy |
| 2026-05-07 | Baird | Maintains | Outperform→Outperform |
| 2026-04-20 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-02-27 | Baird | Maintains | Outperform→Outperform |
| 2026-01-26 | Guggenheim | Maintains | Buy→Buy |
| 2026-01-12 | Lake Street | Maintains | Buy→Buy |
| 2026-01-05 | Guggenheim | Maintains | Buy→Buy |
| 2025-12-22 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-12-12 | BTIG | Maintains | Buy→Buy |
| 2025-11-05 | BTIG | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Castle Biosciences, Inc. (CSTL) stock. Of the recent 75 rating actions, 0 were upgrades and 0 were downgrades. 11 analysts currently cover CSTL.
分析师推荐趋势
CSTL analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$352M
↓ 18.9% YoY
Revenue Next Year
$393M
↑ 11.5% YoY
EPS This Year
$-1.45
EPS Next Year
$-0.93
↓ 36.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast CSTL EPS of $-1.45 for the current fiscal year, based on estimates from 5 analysts. The CSTL revenue forecast is $352M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CSTL 股价预测由两类独立数据源支撑：来自 11 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CSTL 的共识目标价为 $44.80（+122.7% 上行空间），分析师共识为 Buy。
CSTL 的短期预测（明日）为 $20.56（+2.19%）。 CSTL 对 2027 年的股价预测均值为 $23。 CSTL 对 2030 年的预测区间为 $23–$29。
Castle Biosciences, Inc. 在 NASDAQ 上市，代码 CSTL。CSTL 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
CSTL 预测 · 8 个问题根据 11 位华尔街分析师，CSTL 的 12 个月平均目标价为 $44.80，最高 $52.00、最低 $35.00。若有图表，中位目标价可在上方查看。相对当前价 $20.12，隐含约 +122.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.